Phase II Study of Docetaxel for Clinically Asymptomatic High Risk Prostate Cancer Patients
Clinical trial NCT00714376 · TERMINATED
Trial details
- NCT number
- NCT00714376
- Sponsor
- CHU de Quebec-Universite Laval
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-05-01
- Primary completion
- 2008-07-01
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.